Min Zhang

Min Zhang

Auto-generated profile, based on publicly available information

Min Zhang

Department of Environmental Medicine, Icahn School of Medicine at Mount Sinai, New York, USA

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 August 2025 in JNCI: Journal of the National Cancer Institute
Verified
Journal Article
Closed access
YWYaguang Wei
Yaguang Wei
ECEdgar Castro
Edgar Castro
KYKanhua Yin
Kanhua Yin
MZMin Zhang
Min Zhang
HTHannah M. Thompson
Hannah M. Thompson
JSJoel D Schwartz
Joel D Schwartz
Background: Although emerging studies link air pollution to mortality in patients with breast cancer, large-scale evidence remains limited. We aimed to evaluate associations between chronic exposures to three key regulated air pollutants, fine particulate matter, ozone, and nitrogen dioxide, and mortality in a nationwide cohort of older patients with breast cancer. Methods: We constructed a cohort of patients with primary diagnosis of breast cancer aged 65 years or older between 2000 and 2016 using the Surveillance, Epidemiology, and End Results–Medicare database. High-resolution ambient concentrations of annual fine particulate matter, warm-season ozone, and annual nitrogen dioxide were estimated using hybrid models and linked to patients’ residential zip codes as proxy exposures. A 3-pollutant Cox model was fitted to estimate hazard ratios for mortality associated with each pollutant, adjusting for demographics, tumor characteristics, cancer treatments, comorbidities, lifestyle factors, meteorological variables, and neighborhood-level characteristics. Results: Among 593 333 patients with breast cancer, a 1-µg/m3 increase in annual fine particulate matter, a 1-part per billion increase in warm-season ozone, and a 1-part per billion increase in annual nitrogen dioxide were associated with hazard ratios for mortality of 1.0048 (95% CI = 1.0026 to 1.0070), 1.0021 (95% CI = 1.0013 to 1.0029), and 1.0022 (95% CI = 1.0014 to 1.0030), respectively. This finding translated to 49 annual excess deaths attributable to fine particulate matter, 21 to ozone, and 22 to nitrogen dioxide within the cohort. Effects were substantially larger at low exposure levels. Fine particulate matter and nitrogen dioxide had greater effects in younger patients, individuals who received chemotherapy or radiation, and individuals with disease diagnosed at later stages. Conclusion: Our findings identified air pollution as a risk factor for mortality in older patients with breast cancer. Protective measures and air pollution control strategies may help reduce exposure and improve outcomes.

6 February 2026 in Science Advances
Verified
Journal Article
Open access
MZMin Zhang
Min Zhang
ECEdgar Castro
Edgar Castro
ASAlexandra Shtein
Alexandra Shtein
APAdjani A. Peralta
Adjani A. Peralta
MYMahdieh Danesh Yazdi
Mahdieh Danesh Yazdi
YWYaguang Wei
Yaguang Wei
The relationships between chronic exposure to wildfire smoke PM 2.5 (particulate matter with aerodynamic diameter of ≤2.5 μm) and mortality remain poorly understood, with causal evidence being particularly scarce. In this ecological study, we used a doubly robust method, incorporating flexible generalized propensity score estimation that captured potential nonlinearity and interactions among confounders and relaxed the distribution form assumption for exposure, to estimate the effects of annual exposure to wildfire smoke PM 2.5 on all-cause and cause-specific mortality in the contiguous United States from 2006 to 2020. We found that wildfire smoke PM 2.5 was associated with increased mortality rate for all studied outcomes, except for deaths from transport accidents or falls, which served as negative outcome controls. Wildfire smoke PM 2.5 was responsible for ~24,100 all-cause deaths per year in the contiguous United States. The exposure-response curve for all-cause mortality increased monotonically, with no evidence of a “safe” threshold. Among the six cause-specific outcomes, mortality from neurological disease showed the greatest increase per 0.1 μg/m 3 increase in smoke PM 2.5 exposure. Our study provided robust evidence for the chronic effect of wildfire smoke PM 2.5 on mortality, underscoring the urgent need for targeted measures to mitigate the substantial and escalating burden of wildfires.

17 September 2026 in Nature Communications
Verified
Journal Article
Open access
PDF file
MZMin Zhang
Min Zhang
ECEdgar Castro
Edgar Castro
MQMinghao Qiu
Minghao Qiu
MYMahdieh Danesh Yazdi
Mahdieh Danesh Yazdi
BLBoyuan Li
Boyuan Li
YWYaguang Wei
Yaguang Wei
Increasing wildfire activity in the US has made wildfire-specific fine particulate matter (PM 2.5 ) an important and growing source of air pollution, yet its long-term health impacts and relative toxicity compared with non-wildfire PM 2.5 remain unclear. Using a self-controlled design, we examine associations between 2-year average wildfire-specific and non-wildfire PM 2.5 and cardiopulmonary hospitalization risks across 20 US states during 2006–2019. Per 1 µg/m 3 increase, wildfire-specific PM 2.5 is associated with significantly higher hospitalization risks for all cardiopulmonary diseases, with relative risks ranging from 10% for heart failure to 16% for asthma. In contrast, a 1-µg/m 3 increase in non-wildfire PM 2.5 is associated with smaller risk elevations, ranging from 4.7% for chronic obstructive pulmonary disease to 8.5% for hypertension. Stronger associations for both wildfire-specific and non-wildfire PM 2.5 are observed among minorities, metropolitan residents, those with fewer years of education, and more deprived communities. Overall, at an equivalent concentration increase, long-term exposure to wildfire-specific PM 2.5 poses greater cardiopulmonary hospitalization risks than non-wildfire PM 2.5 , underscoring wildfire smoke as a growing public health threat that requires targeted mitigation alongside conventional air quality control strategies.

16 July 2025 in medRxiv
Verified
Preprint
Open access
PDF file
MZMin Zhang
Min Zhang
ECEdgar Castro
Edgar Castro
MQMinghao Qiu
Minghao Qiu
MYMahdieh Danesh Yazdi
Mahdieh Danesh Yazdi
BLBoyuan Li
Boyuan Li
YWYaguang Wei
Yaguang Wei
Importance: Given the increasing wildfire activity in the US, assessment of the health impacts of wildfire-specific fine particulate matter (PM 2.5 ), a growing source of surface air pollution, and its relative toxicity compared to non-wildfire PM 2.5 is needed to support mitigation strategies. Objective: To investigate associations of long-term exposure of wildfire-specific and non-wildfire PM 2.5 with cardiopulmonary hospitalization risks. Design, Setting, and Participants: We obtained over 89 million cardiopulmonary hospitalizations for residents across 20 US states from 2006 to 2019 from the State Inpatient Databases. We assigned estimated 2-year average concentrations of wildfire-specific and non-wildfire PM 2.5 to each hospitalization based on residential ZIP codes to characterize exposure levels. We used a self-controlled design, which is robust to unmeasured confounding, to assess the associations. Exposures: 2-year moving average exposures to wildfire-specific and non-wildfire PM 2.5 from the year of hospitalization to the prior year. Main Outcomes and Measures: The hospitalizations for cardiovascular (ischemic heart disease, cerebrovascular disease, heart failure, arrhythmia, other cardiovascular diseases) and pulmonary diseases (acute respiratory infections, pneumonia, chronic obstructive pulmonary disease [COPD], asthma, other respiratory diseases) were identified based on the first 3 diagnosis codes at discharge. Results: Wildfire-specific PM 2.5 had stronger effects than non-wildfire PM 2.5. Specifically, each 1-µg/m 3 increase in 2-year wildfire-specific PM 2.5 was significantly associated with increased hospitalization risks for all cardiopulmonary diseases, with relative risk ranging from 1.100 (95% CI: 1.091, 1.108) for heart failure to 1.160 (95% CI: 1.142, 1.178) for asthma. In comparison, a 1 µg/m 3 increase in non-wildfire PM 2.5 was associated with increased hospitalization risks for all cardiopulmonary diseases, but with relative risks ranging from 1.047 (95% CI: 1.042, 1.051) for COPD to 1.085 (95% CI: 1.082, 1.088) for hypertension. Stronger effects of both wildfire-specific and non-wildfire PM 2.5 were observed among minorities, individuals with obesity or diabetes, and those living in metropolitan areas, those with fewer years of education, and more deprived communities. Conclusions: Long-term exposure to wildfire-specific PM 2.5 poses a greater risk of cardiopulmonary hospitalization than PM 2.5 from non-wildfire sources. Greater effort should be placed on wildfire management, with particular focus on strategies to reduce smoke in addition to traditional air quality control strategies. Key point: Questions: Does long-term exposure to fine particulate matter from wildfire and non-wildfire sources affect the risk of cardiopulmonary hospitalization differently? Findings: Based on over 89 million hospitalization records for the residents of 20 US states from 2006 to 2019, exposure to fine particulate matter from wildfire was associated with a greater risk of cardiopulmonary hospitalization, compared to those from non-wildfire sources. Meaning: Fine particulate matter from wildfire sources poses a greater health threat than those from non-wildfire sources; greater effort should be placed on wildfire management in addition to relying solely on traditional air quality control strategies.

21 May 2026 in SSRN Electronic Journal
Verified
Preprint
Open access
JZJin-Qin Zhu
Jin-Qin Zhu
YDYan-Ling Deng
Yan-Ling Deng
YMYu Miao
Yu Miao
MZMin Zhang
Min Zhang
LGLong Ge
Long Ge
QZQiang Zeng
Qiang Zeng
Background: Disinfection byproducts (DBPs), particularly haloacetic acids (HAAs), can impair oocyte quality and embryo development, but human evidence remains scarce. To examine whether HAAs in follicular fluid, a critical microenvironment for oocyte growth, are linked with in vitro fertilization (IVF) outcomes.Methods: Dichloroacetic acid (DCAA) and trichloroacetic acid (TCAA) in follicular fluid were measured among 1176 women undergoing 1306 IVF cycles. Generalized linear mixed models assessed associations of HAAs with early IVF outcomes (oocytes, mature oocytes, zygotes with two pronuclei, and good-quality embryos) and clinical pregnancy outcomes (implantation, clinical pregnancy, and live birth). Mediation analyses evaluated early IVF outcomes as mediators of HAAs-related clinical pregnancy outcomes.Findings: Elevated DCAA and TCAA were inversely associated with all IVF outcomes (clinical pregnancy proportions were 16·67% and 10·14% lower for highest vs lowest quartiles; P for trends <0·01). Associations were stronger in women undergoing non-long GnRH agonist regimens and IVF insemination. Oocyte number mediated 50·1%–82·0% of the associations between HAAs and poorer IVF outcomes, and a sequential pathway from oocytes to day-3 embryos mediated 21·05%–33·89% of HAA-related clinical pregnancy outcomes.Interpretation: Elevated follicular fluid HAA concentrations are associated with inferior IVF outcomes. Oocyte and embryo development as the dynamic biological cascades mediate the exposures-related inferior clinical pregnancy outcomes. Our findings strengthen human evidence that exposure to drinking-water DBPs detrimentally affects early reproductive outcomes.

19 October 2026 in SSRN Electronic Journal
Verified
Preprint
Open access
PCPan-Pan Chen
Pan-Pan Chen
YZYu-Lu Zhang
Yu-Lu Zhang
ZHZe-Yang He
Ze-Yang He
KYKe-Xin Yu
Ke-Xin Yu
JZJia-Yue Zeng
Jia-Yue Zeng
QZQiang Zeng
Qiang Zeng
Experimental studies have demonstrated that bisphenol A (BPA) and its structural analogues including bisphenol F (BPF) and bisphenol S (BPS) could impair male reproduction by triggering imbalanced apoptosis of spermatozoa. However, human evidence is limited. A total of 411 male participants were enrolled from an infertility clinic in Wuhan during March-June 2013. Two urine specimens and one semen sample were collected per subject for quantification of urinary BPA, BPF, BPS and detection of spermatozoa apoptosis, respectively. Moreover, polymorphisms of four apoptosis-related genes (Fas rs1800682, Fas rs2234767, FasL rs763110, Caspase3 rs12108497) were measured among 185 subjects with blood samples to investigate the potential modification effects. Multivated linear regression models revealed that higher BPA exposure was dose-dependently associated with increased late apoptosis of spermatozoa, while BPS exposure was associated with increased sperm necrosis. Bayesian kernel machine regression (BKMR) revealed that the mixture of BPA, BPF and BPS was positively correlated with late apoptosis and necrosis of spermatozoa, but was inversely related to early apoptosis. Furthermore, we found that FasL rs763110 and Caspase3 rs12108497 gene polymorphisms modified the associations of urinary bisphenols with spermatozoa apoptosis parameters. For example, the positve association of urinary BPS with spermatozoa necrosis occurred among men with TC/CC genotypes of Caspase3 rs12108497 (P-value for interaction =0.02). Our findings suggest that exposures to BPA and its analogues are associated with increased spermatozoa apoptosis, and genetic susceptibility in apoptosis pathways can modify these effects, highlighting the role of gene-environment interactions in male reproductive health.